Autism Test: Laser Hair Analysis for Older Kids | LinusBio

Beyond Genetics: The Rise of Exposomic Sequencing

For years, the search for biomarkers related to ASD has largely focused on genetic factors. However, a growing body of research suggests that environmental influences play a crucial role in the development of the disorder. LinusBio’s ClearStrand-ASD test taps into this understanding through a groundbreaking approach known as “exposomics.”

Exposomics is the comprehensive study of an individual’s lifetime environmental exposures – from pollutants and toxins to dietary factors and social interactions – and how these exposures interact with their biology. Unlike genetic tests that analyze inherited DNA, ClearStrand-ASD examines the biological record of these exposures, offering a unique perspective on ASD risk.

How Does ClearStrand-ASD Work?

The test utilizes a single strand of hair as a biological archive. Because hair grows continuously, it captures a chronological history of the body’s metabolic and molecular responses to environmental factors. In a CLIA-certified laboratory, proprietary robotics and lasers meticulously analyze hundreds of data points along the hair shaft, identifying patterns correlated with ASD.

This isn’t simply a search for specific molecules; it’s a sophisticated analysis of the interplay between biology and environment. The resulting data is then processed through a proprietary algorithm to assess the likelihood of autism, but critically, the test is designed to rule out ASD with a high degree of accuracy.

The Power of a ‘Rule-Out’ Test

ClearStrand-ASD boasts impressive accuracy metrics: 90% sensitivity and a remarkable 95% negative predictive value. This means that if the test indicates a child is unlikely to have autism, clinicians and families can be highly confident in that result. This confidence can be invaluable in reducing unnecessary testing and anxiety, and in focusing resources on children who truly need further evaluation.

“From the beginning, our goal has been to support families and healthcare providers by providing them with a screening tool that keeps improving as the science advances,” explained Manish Arora, Ph.D., founder and CEO of LinusBio. “As we generate more data and deepen our understanding of the biology, we can expand the test to help a broader group of families and clinicians. Extending access from early childhood to children up to age 10 is an important step toward reaching more families who may benefit from earlier biological insight.”

The expansion to age 10 is supported by data from a global study involving 1,697 participants, currently submitted for peer-reviewed publication. This rigorous research underscores the potential of exposomic sequencing to transform the landscape of ASD screening.

But what does this mean for the future of autism diagnosis? Could exposomic sequencing eventually lead to personalized interventions tailored to an individual’s unique environmental history? And how will this technology impact the broader understanding of neurodevelopmental disorders?

The implications of this technology extend beyond simply identifying or ruling out ASD. It opens the door to a more holistic understanding of how environmental factors influence brain development and overall health.

Learn more about the ClearStrand-ASD test at ClearStrand-ASD and LinusBio’s research at LinusBio.

Frequently Asked Questions About ClearStrand-ASD

• What is the ClearStrand-ASD test?

  The ClearStrand-ASD test is a first-of-its-kind biochemical screening test that uses exposomic sequencing to help healthcare providers rule out autism spectrum disorder (ASD) in children.

• How does exposomic sequencing differ from genetic testing for autism?

  Unlike genetic testing, which analyzes inherited DNA, exposomic sequencing examines the biological record of environmental exposures captured in a strand of hair, providing a unique perspective on ASD risk.

• What is the negative predictive value of the ClearStrand-ASD test?

  The ClearStrand-ASD test has a 95% negative predictive value, meaning that if the test indicates a child likely does not have autism, there is a very high degree of confidence in that result.

• What age range is the ClearStrand-ASD test now validated for?

  The ClearStrand-ASD test is now validated for use in children up to the age of 10, expanding from its previous validation for children under 48 months.

• Is the ClearStrand-ASD test a definitive diagnosis of autism?

  No, the ClearStrand-ASD test is designed as a rule-out test and should be used in conjunction with a comprehensive clinical evaluation by a qualified healthcare professional.